Log in
Login
Password
Remember
Lost password
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Shares  >  Nasdaq  >  Arena Pharmaceuticals, Inc.    ARNA

SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
 News SummaryMost relevantAll newsSector news 
Most relevant news about ARENA PHARMACEUTICALS, INC
09/03 ARENA PHARMACEUTICALS : to Present at the Wells Fargo 2015 Healthcare Conference
08/05 ARENA PHARMACEUTICALS : reports 2Q loss
08/05 ARENA PHARMACEUTICALS : Reports Second Quarter 2015 Financial Results and Provid..
07/30 ARENA PHARMACEUTICALS : to Host Second Quarter 2015 Financial Results and Corpor..
07/29 ARENA PHARMACEUTICALS : Initiates a Phase 2 Clinical Trial of APD334, its S1P1 R..
06/16 ARENA PHARMACEUTICALS : Announces the Departure of Chief Financial Officer
06/04 ARENA PHARMACEUTICALS : Lorcaserin HCl Data to be Presented at American Diabetes..
05/26 ARENA PHARMACEUTICALS : to Present at the Jefferies 2015 Global Healthcare Confe..
05/14 ARENA PHARMACEUTICALS : Eisai and Arena Pharmaceuticals Announce Presentation of..
05/12 ARENA PHARMACEUTICALS : Pharma Enters into Co-Development and Marketing Agreemen..
05/11 ARENA PHARMACEUTICALS : reports 1Q loss
05/11 ARENA PHARMACEUTICALS : Provides Corporate Update and Reports First Quarter 2015..
05/11 ARENA PHARMACEUTICALS : and Roivant Sciences Enter into Collaboration for Nelota..
05/08 ARENA PHARMACEUTICALS : to Present at the Bank of America Merrill Lynch Health C..
05/07 ARENA PHARMACEUTICALS : to Host First Quarter 2015 Financial Results Conference ..
More most relevant news
All news about ARENA PHARMACEUTICALS, INC
09/03 ARENA PHARMACEUTICALS : to Present at the Wells Fargo 2015 Healthcare Conference
08/05 ARENA PHARMACEUTICALS : reports 2Q loss
08/05 ARENA PHARMACEUTICALS : Initiates a Phase 2 Clinical Trial of APD334, its S1P1 R..
08/05 ARENA PHARMACEUTICALS : Reports Second Quarter 2015 Financial Results and Provid..
07/30 ARENA PHARMACEUTICALS : to Host Second Quarter 2015 Financial Results and Corpor..
07/29 ARENA PHARMACEUTICALS : Initiates a Phase 2 Clinical Trial of APD334, its S1P1 R..
06/24 ARENA PHARMACEUTICALS : Announces the Departure of Chief Financial Officer
06/16 ARENA PHARMACEUTICALS : Change in Directors or Principal Officers, Submission of..
06/16 ARENA PHARMACEUTICALS : Announces the Departure of Chief Financial Officer
06/11 ARENA PHARMACEUTICALS : Patent Issued for Processes for the Preparation of 5-HT...
More news
Sector news : Biotechnology & Medical Research - NEC
09/04 GENMAB A/S : U.S. FDA Grants Priority Review for Daratumumab for Double Refracto..
09/03 MEDIVATION : Announces Participation at Upcoming Investor Conference
09/03 QUINTILES TRANSNATIONAL : CEO to Present at Morgan Stanley Global Healthcare Con..
09/03 QIAGEN NV : kit isolates high-quality RNA from exosomes in liquid biopsies
09/03 ISIS PHARMACEUTICALS : to Present at Upcoming Investor Conferences
09/02 INCYTE : Announces Global License Agreement with Jiangsu Hengrui Medicine for SH..
More sector news : Biotechnology & Medical Research - NEC
News from SeekingAlpha
09/04 ARENA : Belviq Advertising Slips - Sales Continue To Slip As Well
09/03 Arena - A Deeper Look At APD-334
08/23 OREXIGEN : Contrave Wins Another Sales Week - Don't Bank On Impressive Numbers
08/23 Vivus Hovers Near 52-Week Lows - Qsymia Sales Not Helping
08/23 Arena - Belviq Sales Will Pace Lower Than Last Year
08/17 Orexigen- Contrave Sales Win The Week But Still Flatter Than Needed


Advertisement
Chart
Duration : Period :
Arena Pharmaceuticals, Inc Technical Analysis Chart | ARNA | US0400471027 | 4-Traders
Income Statement Evolution
More Financials